Avicella Capital

🇦🇺 This Week in Australian Startups #179, 26th September 2026

Weekly roundup recording a dozen raises and acquisitions, Firmus's scheduled float, a new $50m venture fund, a founder share sale, grant winners, an accelerator intake, and an AI agent's government breach.

Also Dynamic Business·DealStreetAsia·This Week in Australian Startups·Dealroom·ABC News Technology

Dementia biotech Kinoxis raises $6.75 million with a $2.5m grant as cherry on top

Melbourne dementia drug developer Kinoxis secured $6.75 million equity led by Main Sequence plus a $2.5 million Medical Research Future Fund grant via CUREator+, funding trials of its agitation and pain drug candidates.

Manufacturing news briefs — stories you might have missed

Roundup of short industry items: Element 25 and Vaxxas win US government grants, Orthocell gets an R&D refund, Convergence Medical completes its Series A, and Monique Conheady takes a Hysata board seat.

Also Startup Daily

Three Aussie startups that raised $46.5 million this week

Roundup of three Australian raises — ElectraLith, Coposit and Convergence Medical — plus Quantum Brilliance naming its Series A backers and Rokt's secondary share sale.

Brisbane robotics surgery startup operates on $5 million Series A

Brisbane arthroscopic robotics maker Convergence Medical has raised a $5 million Series A from US backer Avicella Capital at a valuation topping $30 million, to commercialise its V01 robot in the US.

Also SmartCompany·@AuManufacturing·@AuManufacturing·podtail.nl·@AuManufacturing

Arthroscopic robot developer Convergence Medical seals $5m Series A, boosting its valuation to $30m

Brisbane medtech Convergence Medical has closed a $5 million Series A with US backer Avicella Capital, valuing the surgical robot developer at $30 million as it prepares to commercialise and enter the US market.

Convergence Medical secure $5 million from global investors for world-first surgical robot

Brisbane surgical robotics company Convergence Medical has closed its Series A at AU$5 million from US backer Avicella Capital, valuing it above AU$30 million as it prepares to commercialise its arthroscopic robot VO1.

Five ANZ startups that raised $38.5 million this week

Weekly roundup detailing five raises across Australian and New Zealand startups — Hapana, Kinoxis Therapeutics, Appetise, Bike Matrix and Aglow — worth a combined $38.5 million, naming lead investors and planned expansion for each.

Also SmartCompany·Startup Daily

Kinoxis secures $14.5m in funding and announces expansion of clinical programs to target agitation and aggression in dementia patients

Australian biotech Kinoxis Therapeutics raised $14.5 million in Series B backing from Uniseed, UniSuper and others to fund Phase 2 trials of KNX100 for dementia-related agitation, including a new Australian study.

Also SmartCompany·Startup Daily·Startup Daily